Please enable JavaScript to continue using this application.

Compare $CRL vs $TECH | Chartloom

Compare

$CRL vs $TECH

Charles River Laboratories International Inc · Bio-Techne Corp

CRL

Charles River Laboratories International Inc

TECH

Bio-Techne Corp

Compare $CRL vs $TECH

Comparing Charles River Laboratories International Inc and Bio-Techne Corp

CRLCharles River Laboratories International Inc

TECHBio-Techne Corp

CRLCharles River Laboratories International Inc

Market cap

$14.54B

P/E (TTM)

—

Forward P/E (NTM)

24.21x

Forward P/S (NTM)

3.68x

Rev growth (TTM)

-0.7%

YTD performance

49.1%

52W performance

74.0%

FCF yield

2.5%

TECHBio-Techne Corp

Market cap

$11.29B

P/E (TTM)

62.64x

Forward P/E (NTM)

34.64x

Forward P/S (NTM)

8.77x

Rev growth (TTM)

-0.4%

YTD performance

21.5%

52W performance

19.6%

FCF yield

2.3%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CRL

TECH

Detailed metrics comparison

CRL

Charles River Laboratories International Inc

TECH

Bio-Techne Corp

Market Cap

CRL$14.54B

TECH$11.29B

Enterprise Value

CRL$16.97B

TECH$11.23B

Price

CRL$301.79

TECH$72.46

P/E Ratio

CRLN/A

TECH62.64x

P/S Ratio

CRL3.64x

TECH9.29x

EV/Sales

CRL4.24x

TECH9.24x

EV/EBITDA

CRL19.41x

TECH28.63x

P/B Ratio

CRL4.88x

TECH5.39x

P/FCF Ratio

CRL39.23x

TECH42.89x

EV/FCF

CRL45.79x

TECH42.65x

PEG Ratio

CRLN/A

TECH9.81x

Forward P/E (NTM)

CRL24.21x

TECH34.64x

Forward P/S (NTM)

CRL3.68x

TECH8.77x

Revenue (TTM)

CRL$4.00B

TECH$1.22B

Revenue Growth (YoY)

CRL-0.7%

TECH-0.4%

Forward Rev Growth

CRL2.3%

TECH9.8%

Gross Margin (TTM)

CRL34.6%

TECH66.2%

Operating Margin (TTM)

CRL2.3%

TECH20.7%

EBITDA Margin (TTM)

CRL21.6%

TECH31.6%

Net Margin (TTM)

CRL-6.0%

TECH15.0%

FCF Margin (TTM)

CRL9.3%

TECH21.7%

Net Income (TTM)

CRL$-238M

TECH$182M

FCF (TTM)

CRL$371M

TECH$263M

EPS (TTM)

CRL-$4.97

TECH$1.16

ROE (TTM)

CRL-772.0%

TECH8.9%

ROA (TTM)

CRL-319.0%

TECH7.1%

ROIC (TTM)

CRL-434.0%

TECH8.0%

Cash

CRL$192M

TECH$265M

Debt

CRL$2.63B

TECH$200M

Net Cash/Debt

CRL$-2.43B

TECH$65M

Current Ratio (TTM)

CRL1.35x

TECH4.55x

Quick Ratio (TTM)

CRL0.83x

TECH3.35x

Debt/Equity (TTM)

CRL0.93x

TECH0.09x

Debt/Assets (TTM)

CRL0.0%

TECH0.0%

Interest Coverage (TTM)

CRLN/A

TECHN/A

Net Debt/EBITDA (TTM)

CRL0.00x

TECH0.00x

Beta

CRL1.38

TECH1.29

52W Performance

CRL74.0%

TECH19.6%

YTD Performance

CRL49.1%

TECH21.5%

% from 52W High

CRL-9.5%

TECH-0.3%

% from 52W Low

CRL106.4%

TECH67.7%

Asset Turnover (TTM)

CRL0.53x

TECH0.48x

FCF Yield (TTM)

CRL2.5%

TECH2.3%

Earnings Yield (TTM)

CRL-1.6%

TECH1.6%

Dividend Yield (TTM)

CRLN/A

TECH0.4%

Rule of 40

CRL8.5

TECH21.3

EV/GP/RG

CRL5.20

TECH2.28

Ticker research

View CRL research View TECH research

Metric	CRL Charles River Laboratories International Inc	TECH Bio-Techne Corp
Market & Valuation
Market Cap	$14.54B	$11.29B
Enterprise Value	$16.97B	$11.23B
Price	$301.79	$72.46
P/E Ratio	N/A	62.64x
P/S Ratio	3.64x	9.29x
EV/Sales	4.24x	9.24x
EV/EBITDA	19.41x	28.63x
P/B Ratio	4.88x	5.39x
P/FCF Ratio	39.23x	42.89x
EV/FCF	45.79x	42.65x
PEG Ratio	N/A	9.81x
Forward P/E (NTM)	24.21x	34.64x
Forward P/S (NTM)	3.68x	8.77x
Revenue & Growth
Revenue (TTM)	$4.00B	$1.22B
Revenue Growth (YoY)	-0.7%	-0.4%
Forward Rev Growth	2.3%	9.8%
Profitability
Gross Margin (TTM)	34.6%	66.2%
Operating Margin (TTM)	2.3%	20.7%
EBITDA Margin (TTM)	21.6%	31.6%
Net Margin (TTM)	-6.0%	15.0%
FCF Margin (TTM)	9.3%	21.7%
Net Income (TTM)	$-238M	$182M
FCF (TTM)	$371M	$263M
EPS (TTM)	-$4.97	$1.16
ROE (TTM)	-772.0%	8.9%
ROA (TTM)	-319.0%	7.1%
ROIC (TTM)	-434.0%	8.0%
Financial Health
Cash	$192M	$265M
Debt	$2.63B	$200M
Net Cash/Debt	$-2.43B	$65M
Current Ratio (TTM)	1.35x	4.55x
Quick Ratio (TTM)	0.83x	3.35x
Debt/Equity (TTM)	0.93x	0.09x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.38	1.29
52W Performance	74.0%	19.6%
YTD Performance	49.1%	21.5%
% from 52W High	-9.5%	-0.3%
% from 52W Low	106.4%	67.7%
Efficiency & Yields
Asset Turnover (TTM)	0.53x	0.48x
FCF Yield (TTM)	2.5%	2.3%
Earnings Yield (TTM)	-1.6%	1.6%
Dividend Yield (TTM)	N/A	0.4%
Other
Rule of 40	8.5	21.3
EV/GP/RG	5.20	2.28
Ticker research	View CRL research	View TECH research

Valuation

P/E Ratio

TECH

62.64x

P/S Ratio

CRL

3.64x

TECH

9.29x

EV/FCF

TECH

42.65x

CRL

45.79x

Growth & revenue

Revenue Growth TTM

TECH

-0.4%

CRL

-0.7%

Forward Revenue Growth

TECH

9.8%

CRL

2.3%

Profitability & performance

Gross Margin

TECH

66.2%

CRL

34.6%

ROE

TECH

8.9%

CRL

-772.0%

FCF Yield %

CRL

2.5%

TECH

2.3%

52-Week Performance

CRL

74.0%

TECH

19.6%

Detailed metrics comparison

CRL

Charles River Laboratories International Inc

TECH

Bio-Techne Corp

Market Cap

CRL$14.54B

TECH$11.29B

Enterprise Value

CRL$16.97B

TECH$11.23B

Price

CRL$301.79

TECH$72.46

P/E Ratio

CRLN/A

TECH62.64x

P/S Ratio

CRL3.64x

TECH9.29x

EV/Sales

CRL4.24x

TECH9.24x

EV/EBITDA

CRL19.41x

TECH28.63x

P/B Ratio

CRL4.88x

TECH5.39x

P/FCF Ratio

CRL39.23x

TECH42.89x

EV/FCF

CRL45.79x

TECH42.65x

PEG Ratio

CRLN/A

TECH9.81x

Forward P/E (NTM)

CRL24.21x

TECH34.64x

Forward P/S (NTM)

CRL3.68x

TECH8.77x

Revenue (TTM)

CRL$4.00B

TECH$1.22B

Revenue Growth (YoY)

CRL-0.7%

TECH-0.4%

Forward Rev Growth

CRL2.3%

TECH9.8%

Gross Margin (TTM)

CRL34.6%

TECH66.2%

Operating Margin (TTM)

CRL2.3%

TECH20.7%

EBITDA Margin (TTM)

CRL21.6%

TECH31.6%

Net Margin (TTM)

CRL-6.0%

TECH15.0%

FCF Margin (TTM)

CRL9.3%

TECH21.7%

Net Income (TTM)

CRL$-238M

TECH$182M

FCF (TTM)

CRL$371M

TECH$263M

EPS (TTM)

CRL-$4.97

TECH$1.16

ROE (TTM)

CRL-772.0%

TECH8.9%

ROA (TTM)

CRL-319.0%

TECH7.1%

ROIC (TTM)

CRL-434.0%

TECH8.0%

Cash

CRL$192M

TECH$265M

Debt

CRL$2.63B

TECH$200M

Net Cash/Debt

CRL$-2.43B

TECH$65M

Current Ratio (TTM)

CRL1.35x

TECH4.55x

Quick Ratio (TTM)

CRL0.83x

TECH3.35x

Debt/Equity (TTM)

CRL0.93x

TECH0.09x

Debt/Assets (TTM)

CRL0.0%

TECH0.0%

Interest Coverage (TTM)

CRLN/A

TECHN/A

Net Debt/EBITDA (TTM)

CRL0.00x

TECH0.00x

Beta

CRL1.38

TECH1.29

52W Performance

CRL74.0%

TECH19.6%

YTD Performance

CRL49.1%

TECH21.5%

% from 52W High

CRL-9.5%

TECH-0.3%

% from 52W Low

CRL106.4%

TECH67.7%

Asset Turnover (TTM)

CRL0.53x

TECH0.48x

FCF Yield (TTM)

CRL2.5%

TECH2.3%

Earnings Yield (TTM)

CRL-1.6%

TECH1.6%

Dividend Yield (TTM)

CRLN/A

TECH0.4%

Rule of 40

CRL8.5

TECH21.3

EV/GP/RG

CRL5.20

TECH2.28

Ticker research

View CRL research View TECH research

Metric	CRL Charles River Laboratories International Inc	TECH Bio-Techne Corp
Market & Valuation
Market Cap	$14.54B	$11.29B
Enterprise Value	$16.97B	$11.23B
Price	$301.79	$72.46
P/E Ratio	N/A	62.64x
P/S Ratio	3.64x	9.29x
EV/Sales	4.24x	9.24x
EV/EBITDA	19.41x	28.63x
P/B Ratio	4.88x	5.39x
P/FCF Ratio	39.23x	42.89x
EV/FCF	45.79x	42.65x
PEG Ratio	N/A	9.81x
Forward P/E (NTM)	24.21x	34.64x
Forward P/S (NTM)	3.68x	8.77x
Revenue & Growth
Revenue (TTM)	$4.00B	$1.22B
Revenue Growth (YoY)	-0.7%	-0.4%
Forward Rev Growth	2.3%	9.8%
Profitability
Gross Margin (TTM)	34.6%	66.2%
Operating Margin (TTM)	2.3%	20.7%
EBITDA Margin (TTM)	21.6%	31.6%
Net Margin (TTM)	-6.0%	15.0%
FCF Margin (TTM)	9.3%	21.7%
Net Income (TTM)	$-238M	$182M
FCF (TTM)	$371M	$263M
EPS (TTM)	-$4.97	$1.16
ROE (TTM)	-772.0%	8.9%
ROA (TTM)	-319.0%	7.1%
ROIC (TTM)	-434.0%	8.0%
Financial Health
Cash	$192M	$265M
Debt	$2.63B	$200M
Net Cash/Debt	$-2.43B	$65M
Current Ratio (TTM)	1.35x	4.55x
Quick Ratio (TTM)	0.83x	3.35x
Debt/Equity (TTM)	0.93x	0.09x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.38	1.29
52W Performance	74.0%	19.6%
YTD Performance	49.1%	21.5%
% from 52W High	-9.5%	-0.3%
% from 52W Low	106.4%	67.7%
Efficiency & Yields
Asset Turnover (TTM)	0.53x	0.48x
FCF Yield (TTM)	2.5%	2.3%
Earnings Yield (TTM)	-1.6%	1.6%
Dividend Yield (TTM)	N/A	0.4%
Other
Rule of 40	8.5	21.3
EV/GP/RG	5.20	2.28
Ticker research	View CRL research	View TECH research